Jim Simons Renaissance Technologies
AUM
$64.5B
1-Year Est. Return
42.73%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
1 Year Est. Return
+42.73%
AUM
$64.5B
AUM Growth
-$11.3B
(-15%)
Holding
3,923
Top Buys
| 1 | +$616M | |
| 2 | +$481M | |
| 3 | +$416M | |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| 1 | +$885M | |
| 2 | +$660M | |
| 3 | +$463M | |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Healthcare | 15.77% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Industrials | 9.93% |
| 5 | Financials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
10x Genomics
TXG
$2.4B
| $25.3M | 0.04% |
1,550,539
+505,618
|
|
||
502
Core Scientific
CORZ
$5.2B
| $25.2M | 0.04% |
1,730,463
+175,177
|
|
||
503
Dollar Tree
DLTR
$21.4B
| $25.2M | 0.04% |
204,703
-937,600
|
|
||
504
MasterBrand
MBC
$1.04B
| $25.1M | 0.04% |
2,271,863
+158,500
|
|
||
505
Genpact
G
$6.51B
| $25.1M | 0.04% |
536,000
+4,000
|
|
||
506
Liberty Media Series A
FWONA
$19.2B
| $25.1M | 0.04% |
280,522
-38,500
|
|
||
507
Protolabs
PRLB
$1.29B
| $25M | 0.04% |
493,551
-50,100
|
|
||
508
Sarepta Therapeutics
SRPT
$1.72B
| $25M | 0.04% |
1,159,578
-1,490,600
|
|
||
509
TechnipFMC
FTI
$25.2B
| $24.9M | 0.04% |
558,500
-369,900
|
|
||
510
ANI Pharmaceuticals
ANIP
$1.58B
| $24.8M | 0.04% |
314,402
+41,500
|
|
||
511
Carpenter Technology
CRS
$18B
| $24.8M | 0.04% |
78,800
-53,600
|
|
||
512
Warner Music
WMG
$14.3B
| $24.8M | 0.04% |
808,222
-335,378
|
|
||
513
Solventum
SOLV
$11.6B
| $24.8M | 0.04% |
312,800
+161,000
|
|
||
514
Performance Food Group
PFGC
$13.9B
| $24.8M | 0.04% |
275,307
-172,700
|
|
||
515
Ennis
EBF
$535M
| $24.6M | 0.04% |
1,368,146
-93,800
|
|
||
516
Calix
CALX
$3.32B
| $24.5M | 0.04% |
463,618
+202,800
|
|
||
517
Myers Industries
MYE
$773M
| $24.5M | 0.04% |
1,308,590
-20,407
|
|
||
518
OneSpaWorld
OSW
$2.07B
| $24.5M | 0.04% |
1,180,340
-91,300
|
|
||
519
Cogent Biosciences
COGT
$5.52B
| $24.5M | 0.04% |
689,068
+456,100
|
|
||
520
Veeva Systems
VEEV
$29.4B
| $24.5M | 0.04% |
109,640
-78,360
|
|
||
|
CDTX
521
DELISTED
Cidara Therapeutics
CDTX
| $24.4M | 0.04% |
110,560
+6,300
|
|
||
522
Zscaler
ZS
$24.7B
| $24.4M | 0.04% |
108,300
+2,800
|
|
||
523
Global Ship Lease
GSL
$1.33B
| $24.3M | 0.04% |
693,350
-145,200
|
|
||
524
Philip Morris
PM
$272B
| $24.2M | 0.04% |
+150,900
|
|
||
525
Badger Meter
BMI
$4.28B
| $24.1M | 0.04% |
138,400
-58,800
|
|